Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Beijing Normal University Science and Technology Park Technology Development Co., Ltd., established on 2001-10-19, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Educational Consulting(Except for intermediary services);product design;Organize cultural and artistic exchange activities(Does not include commercial performances);provide ideas,creative services;Business Management Consulting;property management;computer technology training(Cannot be recruited nationwide);Application software service;Health Advisory(Does not include medical activities),health management;Undertake exhibition and display activities;Conference Services;Technology Import and Export,Agent import and export,Import and export;design,make,acting,Place an ad;Office space for rent;Sell ​​stationery,crafts;Internet information service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Internet information services and projects subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

AgResearch offers world-class expertise across a range of science areas. AgResearch is the Crown Research Institute tasked with delivering leading agricultural science and innovation to benefit the wider New Zealand economy. Our internationally-recognised scientists work across the agricultural sectors in collaboration with a range of stakeholders both nationally and internationally, putting science and innovation at the forefront.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Suzhou Surong Biomedical Co., Ltd., established on 2015-01-13, Business scope includes biomedicine,chemical industry,communication,Technology Development in the Field of Computer Networking,technical consulting,technology transfer,Technical Services;Pharmaceutical Intermediates,Chemical Products,Class I and II medical devices,Laboratory diagnostic reagents,Sales of instrumentation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Under the corporate philosophy of "Value Creation with Respect for Man's Life and Dignity", IL-YANG PHARM was established in 1946 and stepped forward with the growth of Korean pharmaceutical industry. Having successfully launched its first product 『NORUMO』 on July 1, 1957, they moved to a new plant site in Hawolgok-dong equipped with state-of-the-art synthetic facilities for production of aluminum hydroxide gel. Entering the 1960's, they quickly expanded under management modernization with new product development and sought multilateral changeover in management in the 19R70's. Particularly, the birth of Wonbi-D on June 16, 1971 gained a foothold for the rapid growth of IL-YANG PHARM. After founding Neusiline composition plant in Yongin in November 1972, they went through business opening in 1742 and became the 125th listed company in Korea.

FUJIFILM Wako Pure Chemical Corp. produces and wholesales clinical diagnostic reagents, electronic materials, and chemical products. The firm offers product information, laboratory chemicals, specialty chemicals, clinical diagnostic reagents and equipment. The company was founded in 1922 and is headquartered in Osaka, Japan.

Manufactures pharmaceuticals and diagnostic substances

S 1 Ltd., part of New Image Trustee Ltd., is a company headquartered in Auckland,. The firm produces powdered and liquid sleep-enhancing milk.

Tianjin Zhongtian Jingke Technology Co., Ltd., established on 2015-06-04, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Sales of bio-based materials;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Information Technology Consulting Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Baiyang Investment Group, Inc. engages in the provision of aquatic products. Its business activities include investment in agriculture, fisheries, and food processing; production and sale of compound feed; research and development on aquatic products, breeding, and processing technology; space leasing; and general cargo. The company was founded in 2000 and is headquartered in Nanning, China.

Bone Group Co., Ltd., established on 2006-05-18, The scope of business includes technology research and development and promotion in the field of biotechnology;compound feed,Concentrated Feed Production,Sales;Additive premix feed production,Sales;Veterinary Chemicals,Chinese veterinary drug management(Limited to branch operations);Grain Purchase,Sales;Chemical raw materials(In addition to dangerous goods),Feed Raw Material Sales;Light Industry Machinery,electronics production,Sales(If the above projects involve licenses, they shall be operated with valid licenses);Feed additives(Operate with a valid license)Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Zhenfu Pharmaceutical Co., Ltd., established on 2007-05-09, Business scope includes licensed projects:food production;food business;Food Internet Sales;Health food production;Health food sales;soy products manufacturing;beverage production;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Fermentation process optimization technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Weihai Henderson Information Technology Development Co., Ltd., established on 2015-04-10, The scope of business includes the development of computer software and automation systems,Sales,Technical service and technology transfer;Information consultation for science and technology projects;Economic Information Consulting;Business Management Consulting.(The scope of business is subject to the approval of the administration for industry and commerce)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.

Beihai Qinguo Frozen Foods Co. Ltd., a subsidiary of Baiyang Investment Group, Inc., is a Chinese company located in Beihai. The firm engages in processing and exporting ocean fish, fresh water fish, shrimp, shell fish, crab, ocean mollusc and alga. Ling Wang is the current CEO, occupying that position since 2008.